Protonix Oral Tablet, Gastro-Resistant 20Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Protonix: Oral tablet, gastro-resistant (20mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_5124.JPG
Protonix 20mg DR Tab
Wyeth Pharmaceuticals Inc, A subsidiary of Pfizer Inc
Pill Identification: P 20 

What is this Medicine?

PANTOPRAZOLE (pan TOE pra zole) prevents the production of acid in the stomach. It is used to treat gastroesophageal reflux disease (GERD), inflammation of the esophagus, and Zollinger-Ellison syndrome.

CVS Pharmacy Patient Statistics for Protonix: Oral tablet, gastro-resistant(20mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Protonix 20mg Delayed-Release Tablet

NDC: 000080843
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Esophagitis, Zollinger-Ellison Syndrome

Sometimes used for but not FDA approved for the following conditions:
Helicobacter Pylori (H. Pylori) Eradication, Dyspepsia, NSAID-induced Ulcer Prophylaxis, Gastric Ulcer, Eosinophilic Esophagitis, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD), Stress Gastritis Prophylaxis, Pyrosis (heartburn)

Storage Information
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Protonix 20mg Delayed-Release Tablet
Drug Image file DrugItem_5124.JPG
Wyeth Pharmaceuticals Inc, A subsidiary of Pfizer Inc
Pill Identification: P 20 
Shape: oval
Color: yellow

Reported Side Effects for Protonix 20mg Delayed-Release Tablet

Lightheadedness Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
Abnormal Heart Rhythm Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Fainting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Heart Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
High White Blood Cells Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Liver Infection Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Intestinal Bleeding Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Blood Clot Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Photosensitivity Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Peripheral Vasodilation Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Eosinophilia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<4.0%*
Severity: MODERATE
Onset: DELAYED
Bruise Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
High Bilirubin Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Heart Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Gas Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
<4.0%*
Severity: MODERATE
Onset: DELAYED
Depression Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
<4.0%*
Severity: MODERATE
Onset: DELAYED
Gallstones Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Cholecystitis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Irregular Heart Rate Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Irregular Heart Beat Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Joint Pain Incidence:
<4.0%*
Severity: MILD
Onset: DELAYED
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Anemia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Dry Mouth Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Balance Problems Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
<4.0%*
Severity: MILD
Onset: RAPID
Low Platelet Count Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Muscle Pain Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Migraine Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
High Triglycerides Incidence:
<4.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Stomach Pain Incidence:
1.0-6.2%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.0-7.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
1.0-12.2%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Injection Site Reaction Incidence:
>1.0%*
Severity: MILD
Onset: RAPID
Upset Stomach Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
>4.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
>4.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
>4.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Protonix

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.